Drugstars ApS - Group

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
Bankruptcy risk for industry  3.3% 3.3% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.0% 21.2%  
Credit score (0-100)  0 0 0 0 5  
Credit rating  N/A N/A N/A N/A B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12

Net sales  0 0 0 0 1,132  
Gross profit  0.0 0.0 0.0 0.0 -2,239  
EBITDA  0.0 0.0 0.0 0.0 -4,682  
EBIT  0.0 0.0 0.0 0.0 -4,682  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 -4,678.3  
Net earnings  0.0 0.0 0.0 0.0 -3,999.2  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 -4,678  

 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 0.0 374  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.3  
Balance sheet total (assets)  0.0 0.0 0.0 0.0 1,346  

Net Debt  0.0 0.0 0.0 0.0 -254  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12

Net sales  0 0 0 0 1,132  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.0 -2,239  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 6  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 1,346  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 0.0 -4,681.5  
Added value %  0.0% 0.0% 0.0% 0.0% -413.7%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 0.0 -1.0  

Profitability 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% -413.7%  
EBIT %  0.0% 0.0% 0.0% 0.0% -413.7%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 0.0% 209.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% -353.4%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% -353.4%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% -413.4%  
ROA %  0.0% 0.0% 0.0% 0.0% -347.5%  
ROI %  0.0% 0.0% 0.0% 0.0% -1,249.6%  
ROE %  0.0% 0.0% 0.0% 0.0% -1,069.2%  

Solidity 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
Equity ratio %  0.0% 0.0% 0.0% 0.0% 27.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 85.9%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 63.4%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% 5.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 845.3%  

Liquidity 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
Quick Ratio  0.0 0.0 0.0 0.0 1.4  
Current Ratio  0.0 0.0 0.0 0.0 1.4  
Cash and cash equivalent  0.0 0.0 0.0 0.0 254.5  

Capital use efficiency 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 98.3  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 88.6  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 118.9%  
Net working capital  0.0 0.0 0.0 0.0 374.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 33.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
N/A
2017
N/A
2018
2018/12
Net sales / employee  0 0 0 0 189  
Added value / employee  0 0 0 0 -780  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -780  
EBIT / employee  0 0 0 0 -780  
Net earnings / employee  0 0 0 0 -667